Evidence map›Paper›PMID 42582739›Full record

ArticleQuantitative imaging in medicine and surgery2026

Evaluation of the ability of hemostatic agents to prevent hemoptysis during ultrasound-guided lung biopsy.

Dongjun Wei, Yuxin Zhang, Jiaxin Tang, Liantu He, Wuxi Chen, Shiyu Zhang, Qing Tang, Haixing Liao, Xinghua Zhou, Hongwei Yang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dongjun Wei *Department of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0001-6427-2783
Yuxin Zhang *Department of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Jiaxin Tang *Department of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Liantu HeDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wuxi ChenDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-9170-3478
Shiyu ZhangDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Qing TangDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Haixing LiaoDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Xinghua ZhouDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Hongwei YangDepartment of Ultrasound, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0009-0006-6799-6633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Low-dose computed tomography screening has substantially improved the detection of peripheral pulmonary lesions (PPLs). Ultrasound-guided lung biopsy is widely used for diagnosis; however, postoperative hemoptysis is a critical complication, and the value of routine prophylactic hemostasis remains unclear. This study aimed to investigate the risk factors for hemoptysis following ultrasound-guided percutaneous lung biopsy and evaluate the advantages and disadvantages of prophylactic hemostatic agents in high- and low-risk patients. Methods: A total of 697 patients who underwent ultrasound-guided peripheral lung biopsy were retrospectively enrolled in this study. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for postoperative hemoptysis, and receiver operating characteristic curve analysis was used to determine the optimal cutoff value for lesion thickness. Subsequently, 126 patients were prospectively recruited and randomly divided into four subgroups: high-risk with hemostatic agents, high-risk without hemostatic agents, low-risk with hemostatic agents, and low-risk without hemostatic agents. Quantitative perioperative indicators, including hemoptysis incidence and volume, blood oxygen saturation, pulse rate, hemoglobin, platelet count, and coagulation function indices, were statistically compared among groups, and hemostatic agent-related adverse complications were recorded. Results: The overall post-biopsy hemoptysis rate was 9.03% (63/697). Multivariate regression analysis confirmed that lesion thickness <15 mm and grade 2 air bronchial signs were independent risk factors for hemoptysis (all P<0.05). The optimal cutoff value of lesion thickness was 15 mm, with an area under the curve (AUC) of 0.713, a sensitivity of 92.4%, and a specificity of 52.4%. For high-risk patients, prophylactic hemostatic agents significantly reduced the hemoptysis rate (15.15% Conclusions: Lesion thickness <15 mm and grade 2 air bronchial signs were identified as independent risk factors for hemoptysis following ultrasound-guided biopsy of PPLs. Prophylactic hemostatic agents may help reduce the hemoptysis rate and volume in patients with at least one high-risk factor. However, given the moderate predictive performance of these risk factors (AUC =0.713), individualized clinical judgment remains essential.

Indexed as

hemoptysishemostatic agentpulmonary peripheral lesionspuncture biopsyUltrasonic guidance

Identifiers

PMID42582739
PMCPMC13458214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.